In the past one year, the Nifty Pharma Index has shed 12.4% as against the 1% gains in the benchmark Nifty 50. Mutual Funds that bet on pharma stocks have fallen 14.2% on an average in the past one year. So far in 2022, they have declined 12.4% on an average, according to Value Research.
F&O Talk: Nifty loses key supports amid tariff turmoil: what’s next? Preeti Chabra weighs in
President Trump’s tariff announcement triggered volatility across global markets, with Indian indices falling 2.6%. Analyst Preeti K. Chabra shares insights on Nifty, Bank Nifty, and